To read this content please select one of the options below:

Medical regulation, spectacular transparency and the blame business

Gerry McGivern (The Department of Management, King's College London, London, UK)
Michael Fischer (The Department of Management, King's College London, London, UK)

Journal of Health Organization and Management

ISSN: 1477-7266

Article publication date: 2 November 2010

1138

Abstract

Purpose

The purpose of this paper is to explore general practitioners' (GPs') and psychiatrists' views and experiences of transparent forms of medical regulation in practice, as well as those of medical regulators and those representing patients and professionals.

Design/methodology/approach

The research included interviews with GPs, psychiatrists and others involved in medical regulation, representing patients and professionals. A qualitative narrative analysis of the interviews was then conducted.

Findings

Narratives suggest rising levels of complaints, legalisation and blame within the National Health Service (NHS). Three key themes emerge. First, doctors feel “guilty until proven innocent” within increasingly legalised regulatory systems and are consequently practising more defensively. Second, regulation is described as providing “spectacular transparency”, driven by political responses to high profile scandals rather than its effects in practice, which can be seen as a social defence. Finally, it is suggested that a “blame business” is driving this form of transparency, in which self‐interested regulators, the media, lawyers, and even some patient organisations are fuelling transparency in a wider culture of blame.

Research limitations/implications

A relatively small number of people were interviewed, so further research testing the findings would be useful.

Practical implications

Transparency has some perverse effects on doctors' practice.

Social implications

Rising levels of blame has perverse consequences for patient care, as doctors are practicing more defensively as a result, as well as significant financial implications for NHS funding.

Originality/value

Transparent forms of regulation are assumed to be beneficial and yet little research has examined its effects in practice. In this paper we highlight a number of perverse effects of transparency in practice.

Keywords

Citation

McGivern, G. and Fischer, M. (2010), "Medical regulation, spectacular transparency and the blame business", Journal of Health Organization and Management, Vol. 24 No. 6, pp. 597-610. https://doi.org/10.1108/14777261011088683

Publisher

:

Emerald Group Publishing Limited

Copyright © 2010, Emerald Group Publishing Limited

Related articles